RxSight (RXST) Cost of Revenue (2020 - 2026)
RxSight's (RXST) quarterly Cost of Revenue came in at $7.4 million in Q1 2026, down 22.69% YoY from $9.6 million in Q1 2025, and up 0.68% on a QoQ basis from $7.3 million in Q4 2025.
RxSight (RXST) Cost of Revenue (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Cost of Revenue data on file, last reported at $7.4 million in Q1 2026.
- Quarterly Cost of Revenue fell 22.69% year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.3 million (down 29.77% YoY) and the FY2025 annual result came in at $31.5 million, down 23.21% from the prior year.
- Cost of Revenue grew to $7.4 million in Q1 2026, from $7.3 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $11.4 million in Q4 2024 to a low of $5.2 million in Q1 2022.
- A 5-year average of $8.4 million and a median of $8.5 million in 2023 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue jumped 119.07% — and 2025, when it sank 39.44%.
- Tracing RXST's Cost of Revenue over 5 years: stood at $8.7 million in 2022, then gained by 26.08% to $10.9 million in 2023, then rose by 4.58% to $11.4 million in 2024, then sank by 35.72% to $7.3 million in 2025, then increased by 0.68% to $7.4 million in 2026.
- The last three Cost of Revenue figures came in at $7.4 million (Q1 2026), $7.3 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 808.60 Mn |
| 10 | RxSight | 251.23 Mn | -153.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.40 Mn |
| Mar 31, 2026 | 7.40 Mn |
| Dec 31, 2025 | 7.35 Mn |
| Dec 31, 2025 | 7.35 Mn |
| Sep 30, 2025 | 6.11 Mn |
| Sep 30, 2025 | 6.11 Mn |
| Jun 30, 2025 | 8.45 Mn |
| Jun 30, 2025 | 8.45 Mn |
| Mar 31, 2025 | 9.57 Mn |
| Mar 31, 2025 | 9.57 Mn |
| Dec 31, 2024 | 11.43 Mn |
| Dec 31, 2024 | 11.43 Mn |
| Sep 30, 2024 | 10.09 Mn |
| Sep 30, 2024 | 10.09 Mn |
| Jun 30, 2024 | 10.64 Mn |
| Jun 30, 2024 | 10.64 Mn |
| Mar 31, 2024 | 8.83 Mn |
| Mar 31, 2024 | 8.83 Mn |
| Dec 31, 2023 | 10.93 Mn |
| Dec 31, 2023 | 10.93 Mn |